Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Hagberg

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Diving and Hyperbaric Medicine|December 22, 2015
Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot studyPashtun Shahim, Per Arnell, Andreas Kvarnström, et al.
Plos One|October 14, 2021
Effects on health-related quality of life in the randomized, controlled crossover trial ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis)Anna Turesson Wadell, Linnea Bärebring, Erik Hulander, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 18, 2010
Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapyAylin Yilmaz, Chris Verhofstede, Antonio D'Avolio, et al.
Open Forum Infectious Diseases|March 2, 2023
Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV InfectionArvid Edén, Frida Rydberg, Aylin Yilmaz, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkersMagnus Gisslen, Lars Hagberg, Lars Rosengren, et al.
Plos One|December 1, 2020
Towards capability-adjusted life years in public health and social welfare: Results from a Swedish survey on ranking capabilitiesAnna Månsdotter, Björn Ekman, Kaspar Walter Meili, et al.
BMC Neurology|January 9, 2013
Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infectionDaniel Bremell, Niklas Mattsson, Mikael Edsbagge, et al.
Clinical Biochemistry|November 27, 2013
Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infectionsDaniel Bremell, Niklas Mattsson, Fredrik Wallin, et al.
Plos One|November 19, 2013
Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs studySanjib Saha, Katarina Steen Carlsson, Ulf-G Gerdtham, et al.
Journal of Combinatorial Chemistry|July 12, 2005
Solid-phase synthesis of a 6-phenylquinolin-2(1H)-one library directed toward nuclear hormone receptorsMarcus Ruda, Nina Kann, Sandra Gordon, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Diving and Hyperbaric Medicine|December 22, 2015
Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot studyPashtun Shahim, Per Arnell, Andreas Kvarnström, et al.
Plos One|October 14, 2021
Effects on health-related quality of life in the randomized, controlled crossover trial ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis)Anna Turesson Wadell, Linnea Bärebring, Erik Hulander, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 18, 2010
Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapyAylin Yilmaz, Chris Verhofstede, Antonio D'Avolio, et al.
Open Forum Infectious Diseases|March 2, 2023
Residual Central Nervous System Immune Activation Is Not Prevented by Antiretroviral Therapy Initiated During Early Chronic HIV InfectionArvid Edén, Frida Rydberg, Aylin Yilmaz, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkersMagnus Gisslen, Lars Hagberg, Lars Rosengren, et al.
Plos One|December 1, 2020
Towards capability-adjusted life years in public health and social welfare: Results from a Swedish survey on ranking capabilitiesAnna Månsdotter, Björn Ekman, Kaspar Walter Meili, et al.
BMC Neurology|January 9, 2013
Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infectionDaniel Bremell, Niklas Mattsson, Mikael Edsbagge, et al.
Clinical Biochemistry|November 27, 2013
Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infectionsDaniel Bremell, Niklas Mattsson, Fredrik Wallin, et al.
Plos One|November 19, 2013
Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs studySanjib Saha, Katarina Steen Carlsson, Ulf-G Gerdtham, et al.
Journal of Combinatorial Chemistry|July 12, 2005
Solid-phase synthesis of a 6-phenylquinolin-2(1H)-one library directed toward nuclear hormone receptorsMarcus Ruda, Nina Kann, Sandra Gordon, et al.
Pageof 14